Rapid Remission of a Second Primary Kaposis Sarcoma With Thalidomide Treatment in a Patient Receiving Adjuvant Chemotherapy for Colon Cancer

Chih-Ming Chou, Kuei-Fang Chou, Wei-Yu Chen, En-Kwang Lin, Yi-Fang Chang, Ying-Wen Su


Kaposis sarcoma is a human herpes virus 8 associated-angioproliferative disorder, which is commonly associated with immunocompromised conditions such as those which arise in renal transplant recipients, or in acquired immune-deficiency syndrome (AIDS) cases. It is less well described, however, in patients with solid tumors undergoing adjuvant chemotherapy after surgery. We report the case of an HIV-negative heterosexual Taiwanese man who developed a second primary Kaposis sarcoma 5 months after the start of adjuvant chemotherapy for stage III colon cancer. Thalidomide treatment was started after the patient completed 6 months of adjuvant chemotherapy, and the Kaposis sarcoma regressed within 2 months. The case reported here suggests that pre-existing HHV-8 infection and adjuvant chemotherapy may predispose these patients to a second malignancy with Kaposis sarcoma. Restoration of immune function through cessation of chemotherapy and thalidomide administration may accelerate the regression of the disease, thereby avoiding the need for radiotherapy or anthracycline-based chemotherapy.

J Med Cases. 2013;4(7):466-470
doi: https://doi.org/10.4021/jmc1199w



Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.